EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H22N2O |
| Net Charge | 0 |
| Average Mass | 246.354 |
| Monoisotopic Mass | 246.17321 |
| SMILES | CCN(CC)C(=O)C1(c2ccccc2)CC1CN |
| InChI | InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3 |
| InChIKey | GJJFMKBJSRMPLA-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| milnacipran (CHEBI:135005) has role analgesic (CHEBI:35480) |
| milnacipran (CHEBI:135005) has role antidepressant (CHEBI:35469) |
| milnacipran (CHEBI:135005) has role antispasmodic drug (CHEBI:53784) |
| milnacipran (CHEBI:135005) is a acetamides (CHEBI:22160) |
| Synonyms | Source |
|---|---|
| Impulsor | ChEMBL |
| midalcipran | DrugCentral |
| (+/-)-Milnacipran | DrugCentral |
| Milnacipran | ChEMBL |
| milnacipran HCl | DrugCentral |
| milnacipran hydrochloride | DrugCentral |
| Brand Name | Source |
|---|---|
| Milnacipran pierre fabre medicament | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 1808 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:92623-85-3 | DrugCentral |
| Citations |
|---|